Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 2,689,760 |
|
|||||
| News | - | ||||||
| Day High | 137.22 | Low High |
|||||
| Day Low | 135.00 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Novo Nordisk | NVO | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 1.54 | 1.15% | 135.565 | 14:44:10 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 136.46 | 135.00 | 137.22 | 134.03 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 40,521 | 2,689,760 | $ 136.37 | $ 366,802,033 | - | 75.56 - 138.28 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 14:44:11 | 98 | $ 135.56 | USD |
Novo Nordisk (NVO) Options Flow Summary
Novo Nordisk Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 619.85B | 4.51B | - | 232.26B | 83.68B | 18.56 | 7.41 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Novo Nordisk News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NVO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 133.15 | 137.22 | 130.85 | 133.53 | 2,826,478 | 2.41 | 1.81% |
| 1 Month | 123.69 | 137.22 | 121.2902 | 128.73 | 4,027,309 | 11.88 | 9.60% |
| 3 Months | 120.11 | 138.28 | 118.91 | 128.83 | 4,521,034 | 15.46 | 12.87% |
| 6 Months | 104.30 | 138.28 | 94.7313 | 118.86 | 4,491,434 | 31.27 | 29.98% |
| 1 Year | 84.08 | 138.28 | 75.56 | 108.91 | 3,643,018 | 51.49 | 61.23% |
| 3 Years | 40.905 | 138.28 | 39.355 | 87.26 | 2,101,188 | 94.66 | 231.41% |
| 5 Years | 23.89 | 138.28 | 23.41 | 69.94 | 1,809,796 | 111.68 | 467.46% |
Novo Nordisk Description
| Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders. |
